KEGG   PATHWAY: bacu05205
Entry
bacu05205                   Pathway                                
Name
Proteoglycans in cancer - Balaenoptera acutorostrata scammoni (minke whale)
Description
Many proteoglycans (PGs) in the tumor microenvironment have been shown to be key macromolecules that contribute to biology of various types of cancer including proliferation, adhesion, angiogenesis and metastasis, affecting tumor progress. The four main types of proteoglycans include hyaluronan (HA), which does not occur as a PG but in free form, heparan sulfate proteoglycans (HSPGs), chondroitin sulfate proteoglycans (CSPGs), dematan sulfate proteoglycans (DSPG) and keratan sulfate proteoglycans (KSPGs) [BR:00535]. Among these proteoglycans such as HA, acting with CD44, promotes tumor cell growth and migration, whereas other proteoglycans such as syndecans (-1~-4), glypican (-1, -3) and perlecan may interact with growth factors, cytokines, morphogens and enzymes through HS chains [BR:00536], also leading to tumor growth and invasion. In contrast, some of the small leucine-rich proteolgycans, such as decorin and lumican, can function as tumor repressors, and modulate the signaling pathways by the interaction of their core proteins and multiple receptors.
Class
Human Diseases; Cancer: overview
Pathway map
bacu05205  Proteoglycans in cancer
bacu05205

Organism
Balaenoptera acutorostrata scammoni (minke whale) [GN:bacu]
Gene
103014196  CD44; CD44 molecule (Indian blood group) [KO:K06256]
103001801  SRC; SRC proto-oncogene, non-receptor tyrosine kinase [KO:K05704] [EC:2.7.10.2]
103018861  HCLS1; hematopoietic cell-specific Lyn substrate 1 [KO:K06106]
103015814  CTTN; cortactin [KO:K06106]
103002640  ERBB2; erb-b2 receptor tyrosine kinase 2 [KO:K05083] [EC:2.7.10.1]
103010512  GRB2; growth factor receptor bound protein 2 [KO:K04364]
103002083  VAV2; vav guanine nucleotide exchange factor 2 [KO:K05730]
103018979  VAV1; vav guanine nucleotide exchange factor 1 [KO:K05730]
103019070  VAV3; vav guanine nucleotide exchange factor 3 [KO:K05730]
103006545  HRAS; HRas proto-oncogene, GTPase [KO:K02833]
103015457  KRAS; KRAS proto-oncogene, GTPase [KO:K07827]
103004931  NRAS; neuroblastoma RAS viral oncogene homolog [KO:K07828]
103010530  RRAS; related RAS viral (r-ras) oncogene homolog [KO:K07829]
103008711  RRAS2; related RAS viral (r-ras) oncogene homolog 2 [KO:K07830]
103016009  MRAS; muscle RAS oncogene homolog [KO:K07831]
103002372  BRAF; B-Raf proto-oncogene, serine/threonine kinase [KO:K04365] [EC:2.7.11.1]
103014337  RAF1; Raf-1 proto-oncogene, serine/threonine kinase [KO:K04366] [EC:2.7.11.1]
103020975  ARAF; A-Raf proto-oncogene, serine/threonine kinase [KO:K08845] [EC:2.7.11.1]
103017381  MAP2K1; mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]
103018627  MAP2K2; mitogen-activated protein kinase kinase 2 [KO:K04369] [EC:2.7.12.2]
102999619  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]
103002590  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]
103007995  RAC1; ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1) [KO:K04392]
103019637  IQGAP1; IQ motif containing GTPase activating protein 1 [KO:K16848]
103008817  CDC42; cell division cycle 42 [KO:K04393]
102998249  ELK1; ELK1, ETS transcription factor [KO:K04375]
103009601  ESR1; estrogen receptor 1 [KO:K08550]
103013404  CCND1; cyclin D1 [KO:K04503]
103005004  ACTG1; actin gamma 1 [KO:K05692]
103015338  ACTB; actin beta [KO:K05692]
103000025  FLNA; filamin A [KO:K04437]
103010714  PAK1; p21 (RAC1) activated kinase 1 [KO:K04409] [EC:2.7.11.1]
103016623  TIAM1; T-cell lymphoma invasion and metastasis 1 [KO:K05731]
103011772  ARHGEF1; Rho guanine nucleotide exchange factor 1 [KO:K12330]
103019793  RHOA; ras homolog family member A [KO:K04513]
103002971  rho-associated protein kinase 1-like [KO:K04514] [EC:2.7.11.1]
102999355  ROCK2; Rho associated coiled-coil containing protein kinase 2 [KO:K17388] [EC:2.7.11.1]
103014840  ANK1; ankyrin 1, erythrocytic [KO:K10380]
103011300  ANK2; ankyrin 2 [KO:K09255]
103013402  ANK3; ankyrin 3 [KO:K09259]
102999413  GAB1; GRB2 associated binding protein 1 [KO:K09593]
103012691  PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha [KO:K00922] [EC:2.7.1.153]
103012931  PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta [KO:K00922] [EC:2.7.1.153]
103014043  PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta [KO:K00922] [EC:2.7.1.153]
103008077  PIK3R3; phosphoinositide-3-kinase regulatory subunit 3 [KO:K02649]
103009307  PIK3R2; phosphoinositide-3-kinase regulatory subunit 2 [KO:K02649]
103007464  PIK3R1; phosphoinositide-3-kinase regulatory subunit 1 [KO:K02649]
103002026  AKT3; AKT serine/threonine kinase 3 [KO:K04456] [EC:2.7.11.1]
103013147  AKT1; AKT serine/threonine kinase 1 [KO:K04456] [EC:2.7.11.1]
103004139  AKT2; AKT serine/threonine kinase 2 [KO:K04456] [EC:2.7.11.1]
103013771  SLC9A1; solute carrier family 9 member A1 [KO:K05742]
103017316  PPP1CC; protein phosphatase 1 catalytic subunit gamma [KO:K06269] [EC:3.1.3.16]
103000500  PPP1CB; protein phosphatase 1 catalytic subunit beta [KO:K06269] [EC:3.1.3.16]
103008250  serine/threonine-protein phosphatase PP1-gamma catalytic subunit B-like [KO:K06269] [EC:3.1.3.16]
103008309  PPP1CA; protein phosphatase 1 catalytic subunit alpha [KO:K06269] [EC:3.1.3.16]
103020020  PPP1R12A; protein phosphatase 1 regulatory subunit 12A [KO:K06270]
103012518  PPP1R12B; protein phosphatase 1 regulatory subunit 12B [KO:K12329]
103010788  PPP1R12C; protein phosphatase 1 regulatory subunit 12C [KO:K17457]
103002190  ARHGEF12; Rho guanine nucleotide exchange factor 12 [KO:K07532]
103016185  PLCE1; phospholipase C epsilon 1 [KO:K05860] [EC:3.1.4.11]
103010644  ITPR1; inositol 1,4,5-trisphosphate receptor type 1 [KO:K04958]
103018280  ITPR2; inositol 1,4,5-trisphosphate receptor type 2 [KO:K04959]
102999302  ITPR3; inositol 1,4,5-trisphosphate receptor type 3 [KO:K04960]
102999844  CAMK2G; calcium/calmodulin dependent protein kinase II gamma [KO:K04515] [EC:2.7.11.17]
103018247  CAMK2A; calcium/calmodulin dependent protein kinase II alpha [KO:K04515] [EC:2.7.11.17]
103003341  CAMK2B; calcium/calmodulin dependent protein kinase II beta [KO:K04515] [EC:2.7.11.17]
103012734  CAMK2D; calcium/calmodulin dependent protein kinase II delta [KO:K04515] [EC:2.7.11.17]
102997306  NANOG; Nanog homeobox [KO:K10164]
103013532  DDX5; DEAD-box helicase 5 [KO:K12823] [EC:5.6.2.7]
103019454  DROSHA; drosha ribonuclease III [KO:K03685] [EC:3.1.26.3]
102997405  signal transducer and activator of transcription 3-like [KO:K04692]
103008157  STAT3; signal transducer and activator of transcription 3 (acute-phase response factor) [KO:K04692]
103012131  TWIST1; twist family bHLH transcription factor 1 [KO:K09069]
103005653  TWIST2; twist family bHLH transcription factor 2 [KO:K09069]
102998026  HOXD10; homeobox D10 [KO:K09295]
103020810  DCN; decorin [KO:K04660]
103014780  IGF1; insulin like growth factor 1 [KO:K05459]
103015537  IGF1R; insulin like growth factor 1 receptor [KO:K05087] [EC:2.7.10.1]
103004460  MTOR; mechanistic target of rapamycin [KO:K07203] [EC:2.7.11.1]
103010966  PDPK1; 3-phosphoinositide dependent protein kinase 1 [KO:K06276] [EC:2.7.11.1]
103019799  RPS6KB1; ribosomal protein S6 kinase B1 [KO:K04688] [EC:2.7.11.1]
102998750  RPS6KB2; ribosomal protein S6 kinase B2 [KO:K04688] [EC:2.7.11.1]
103002380  EIF4B; eukaryotic translation initiation factor 4B [KO:K03258]
103010179  40S ribosomal protein S6-like [KO:K02991]
103003760  RPS6; ribosomal protein S6 [KO:K02991]
103017029  EGFR; epidermal growth factor receptor [KO:K04361] [EC:2.7.10.1]
103001646  CAV1; caveolin 1 [KO:K06278]
103001094  CAV2; caveolin 2 [KO:K12958]
103014158  CAV3; caveolin 3 [KO:K12959]
103008839  CD63; CD63 molecule [KO:K06497]
103005082  CDKN1A; cyclin dependent kinase inhibitor 1A [KO:K06625]
103019939  CASP3; caspase 3 [KO:K02187] [EC:3.4.22.56]
103002687  TGFB1; transforming growth factor beta 1 [KO:K13375]
102998386  TLR2; toll like receptor 2 [KO:K10159]
103015759  TLR4; toll like receptor 4 [KO:K10160]
103004767  PDCD4; programmed cell death 4 [KO:K16865]
103005897  TNF; tumor necrosis factor [KO:K03156]
103007028  IL12B; interleukin 12B [KO:K05425]
103015964  ERBB3; erb-b2 receptor tyrosine kinase 3 [KO:K05084] [EC:2.7.10.1]
103004826  ERBB4; erb-b2 receptor tyrosine kinase 4 [KO:K05085] [EC:2.7.10.1]
103016933  MYC; v-myc avian myelocytomatosis viral oncogene homolog [KO:K04377]
103019097  CTNNB1; catenin beta 1 [KO:K02105]
103008124  HIF1A; hypoxia inducible factor 1 alpha subunit [KO:K08268]
103014489  TFAP4; transcription factor AP-4 [KO:K09108]
103008131  VEGFA; vascular endothelial growth factor A [KO:K05448]
102999852  KDR; kinase insert domain receptor [KO:K05098] [EC:2.7.10.1]
103002086  MET; MET proto-oncogene, receptor tyrosine kinase [KO:K05099] [EC:2.7.10.1]
103016132  CBL; Cbl proto-oncogene [KO:K04707] [EC:2.3.2.27]
103020914  TIMP3; TIMP metallopeptidase inhibitor 3 [KO:K16866]
103019307  THBS1; thrombospondin 1 [KO:K16857]
103016736  MMP2; matrix metallopeptidase 2 [KO:K01398] [EC:3.4.24.24]
103016628  MMP9; matrix metallopeptidase 9 [KO:K01403] [EC:3.4.24.35]
102997711  LUM; lumican [KO:K08122]
102999836  FASLG; Fas ligand [KO:K04389]
103020508  FAS; Fas cell surface death receptor [KO:K04390]
103017808  MDM2; MDM2 proto-oncogene [KO:K06643] [EC:2.3.2.27]
103003426  TP53; tumor protein p53 [KO:K04451]
103001453  TGFB2; transforming growth factor beta 2 [KO:K13376]
103005078  SMAD2; SMAD family member 2 [KO:K04500]
102999760  HPSE; heparanase [KO:K07964] [EC:3.2.1.166]
102998284  HPSE2; heparanase 2 (inactive) [KO:K07965] [EC:3.2.1.-]
103005274  SDC1; syndecan 1 [KO:K06257]
103005948  PLAU; plasminogen activator, urokinase [KO:K01348] [EC:3.4.21.73]
103017672  PLAUR; plasminogen activator, urokinase receptor [KO:K03985]
103019929  collagen alpha-1(I) chain-like [KO:K06236]
103006766  collagen alpha-2(I) chain-like [KO:K06236]
103016586  ITGA2; integrin subunit alpha 2 [KO:K06481]
103008019  ITGB1; integrin subunit beta 1 [KO:K05719]
103000100  VTN; vitronectin [KO:K06251]
103000411  ITGAV; integrin subunit alpha V [KO:K06487]
103005345  ITGB3; integrin subunit beta 3 [KO:K06493]
103018975  FN1; fibronectin 1 [KO:K05717]
103010943  ITGB5; integrin subunit beta 5 [KO:K06588]
102997605  hepatocyte growth factor-like [KO:K05460]
103017176  WNT1; Wnt family member 1 [KO:K03209]
103008493  FZD7; frizzled class receptor 7 [KO:K02432]
103019298  FZD1; frizzled class receptor 1 [KO:K02432]
102998345  FZD2; frizzled class receptor 2 [KO:K02235]
103010053  FZD3; frizzled class receptor 3 [KO:K02329]
103020165  FZD4; frizzled class receptor 4 [KO:K02354]
102999603  FZD6; frizzled class receptor 6 [KO:K02376]
103015505  FZD9; frizzled class receptor 9 [KO:K02842]
103006051  FZD10; frizzled class receptor 10 [KO:K02842]
103011640  ITGA5; integrin subunit alpha 5 [KO:K06484]
103001944  SDC2; syndecan 2 [KO:K16336]
103012336  EZR; ezrin [KO:K08007]
102998582  RDX; radixin [KO:K05762]
103015689  MSN; moesin [KO:K05763]
103005141  SDC4; syndecan 4 [KO:K16338]
103015722  FGF2; fibroblast growth factor 2 [KO:K18497]
103017733  FGFR1; fibroblast growth factor receptor 1 [KO:K04362] [EC:2.7.10.1]
103015944  FRS2; fibroblast growth factor receptor substrate 2 [KO:K12461]
103004467  PTPN11; protein tyrosine phosphatase, non-receptor type 11 [KO:K07293] [EC:3.1.3.48]
103008474  tyrosine-protein phosphatase non-receptor type 11-like [KO:K07293] [EC:3.1.3.48]
102999196  SOS1; SOS Ras/Rac guanine nucleotide exchange factor 1 [KO:K03099]
103019365  SOS2; SOS Ras/Rho guanine nucleotide exchange factor 2 [KO:K03099]
103016663  PLCG1; phospholipase C gamma 1 [KO:K01116] [EC:3.1.4.11]
103014764  PLCG2; phospholipase C gamma 2 [KO:K05859] [EC:3.1.4.11]
103004532  PRKCA; protein kinase C alpha [KO:K02677] [EC:2.7.11.13]
103012542  PRKCB; protein kinase C beta [KO:K19662] [EC:2.7.11.13]
103017540  PRKCG; protein kinase C gamma [KO:K19663] [EC:2.7.11.13]
103011250  NUDT16L1; nudix hydrolase 16 like 1 [KO:K16867]
103003171  PXN; paxillin [KO:K05760]
103013388  PTK2; protein tyrosine kinase 2 [KO:K05725] [EC:2.7.10.2]
102998316  HBEGF; heparin binding EGF like growth factor [KO:K08523]
103012530  GPC1; glypican 1 [KO:K08107]
102997276  IGF2; insulin like growth factor 2 [KO:K13769]
103015549  GPC3; glypican 3 [KO:K08109]
103003752  WNT2; Wnt family member 2 [KO:K00182]
103013943  WNT2B; Wnt family member 2B [KO:K00182]
103020927  WNT3A; Wnt family member 3A [KO:K00312]
103015001  WNT3; Wnt family member 3 [KO:K00312]
103009300  WNT4; Wnt family member 4 [KO:K00408]
103001360  protein Wnt-5a-like [KO:K00444]
103020226  WNT5B; Wnt family member 5B [KO:K00444]
102997453  WNT6; Wnt family member 6 [KO:K00445]
103004744  WNT7B; Wnt family member 7B [KO:K00572]
103016619  protein Wnt-7a-like [KO:K00572]
103014029  WNT8B; Wnt family member 8B [KO:K00714]
103004198  WNT8A; Wnt family member 8A [KO:K00714]
103012928  WNT9A; Wnt family member 9A [KO:K01064]
103020386  WNT9B; Wnt family member 9B [KO:K01064]
103000687  WNT10A; Wnt family member 10A [KO:K01357]
103016899  WNT10B; Wnt family member 10B [KO:K01357]
103016115  WNT11; Wnt family member 11 [KO:K01384]
103018475  WNT16; Wnt family member 16 [KO:K01558]
102998170  SHH; sonic hedgehog [KO:K11988]
103001238  IHH; indian hedgehog [KO:K11989]
103004681  PTCH1; patched 1 [KO:K06225]
102998146  SMO; smoothened, frizzled class receptor [KO:K06226]
103016583  HSPG2; heparan sulfate proteoglycan 2 [KO:K06255]
103009986  cathepsin L1-like [KO:K01365] [EC:3.4.22.15]
103003105  CTSL; cathepsin L [KO:K01365] [EC:3.4.22.15]
103000011  PRKACA; protein kinase cAMP-activated catalytic subunit alpha [KO:K04345] [EC:2.7.11.11]
103008319  PRKACB; protein kinase cAMP-activated catalytic subunit beta [KO:K04345] [EC:2.7.11.11]
103009947  MAPK12; mitogen-activated protein kinase 12 [KO:K04441] [EC:2.7.11.24]
102999798  mitogen-activated protein kinase 12-like [KO:K04441] [EC:2.7.11.24]
103002378  MAPK13; mitogen-activated protein kinase 13 [KO:K04441] [EC:2.7.11.24]
103008537  MAPK14; mitogen-activated protein kinase 14 [KO:K04441] [EC:2.7.11.24]
103002353  HSPB2; heat shock protein family B (small) member 2 [KO:K09543]
103005216  PTPN6; protein tyrosine phosphatase, non-receptor type 6 [KO:K05697] [EC:3.1.3.48]
Compound
C00426  Dermatan sulfate
C00573  Keratan sulfate
C00607  Chondroitin sulfate
C00925  Heparan sulfate
G10505  Hyaluronic acid
G13063  Binding domain for FGF2 in heparin/heparan sulfate
G13064  Binding domain for HGF in heparin/heparan sulfate
Reference
  Authors
Bourguignon LY
  Title
Hyaluronan-mediated CD44 activation of RhoGTPase signaling and cytoskeleton function promotes tumor progression.
  Journal
Semin Cancer Biol 18:251-9 (2008)
DOI:10.1016/j.semcancer.2008.03.007
Reference
  Authors
Briggs MW, Sacks DB
  Title
IQGAP1 as signal integrator: Ca2+, calmodulin, Cdc42 and the cytoskeleton.
  Journal
FEBS Lett 542:7-11 (2003)
DOI:10.1016/S0014-5793(03)00333-8
Reference
  Authors
Bourguignon LY, Singleton PA, Zhu H, Diedrich F
  Title
Hyaluronan-mediated CD44 interaction with RhoGEF and Rho kinase promotes Grb2-associated binder-1 phosphorylation and phosphatidylinositol 3-kinase signaling leading to cytokine (macrophage-colony stimulating factor) production and breast tumor progression.
  Journal
J Biol Chem 278:29420-34 (2003)
DOI:10.1074/jbc.M301885200
Reference
  Authors
Bourguignon LY, Gilad E, Rothman K, Peyrollier K
  Title
Hyaluronan-CD44 interaction with IQGAP1 promotes Cdc42 and ERK signaling, leading to actin binding, Elk-1/estrogen receptor transcriptional activation, and ovarian cancer progression.
  Journal
J Biol Chem 280:11961-72 (2005)
DOI:10.1074/jbc.M411985200
Reference
  Authors
Turley EA, Noble PW, Bourguignon LY
  Title
Signaling properties of hyaluronan receptors.
  Journal
J Biol Chem 277:4589-92 (2002)
DOI:10.1074/jbc.R100038200
Reference
PMID:9346940
  Authors
Bourguignon LY, Zhu H, Chu A, Iida N, Zhang L, Hung MC
  Title
Interaction between the adhesion receptor, CD44, and the oncogene product, p185HER2, promotes human ovarian tumor cell activation.
  Journal
J Biol Chem 272:27913-8 (1997)
DOI:10.1074/jbc.272.44.27913
Reference
  Authors
Neill T, Schaefer L, Iozzo RV
  Title
Decorin: a guardian from the matrix.
  Journal
Am J Pathol 181:380-7 (2012)
DOI:10.1016/j.ajpath.2012.04.029
Reference
  Authors
Neill T, Painter H, Buraschi S, Owens RT, Lisanti MP, Schaefer L, Iozzo RV
  Title
Decorin antagonizes the angiogenic network: concurrent inhibition of Met, hypoxia inducible factor 1alpha, vascular endothelial growth factor A, and induction of thrombospondin-1 and TIMP3.
  Journal
J Biol Chem 287:5492-506 (2012)
DOI:10.1074/jbc.M111.283499
Reference
  Authors
Goldoni S, Humphries A, Nystrom A, Sattar S, Owens RT, McQuillan DJ, Ireton K, Iozzo RV
  Title
Decorin is a novel antagonistic ligand of the Met receptor.
  Journal
J Cell Biol 185:743-54 (2009)
DOI:10.1083/jcb.200901129
Reference
  Authors
Zhu JX, Goldoni S, Bix G, Owens RT, McQuillan DJ, Reed CC, Iozzo RV
  Title
Decorin evokes protracted internalization and degradation of the epidermal growth factor receptor via caveolar endocytosis.
  Journal
J Biol Chem 280:32468-79 (2005)
DOI:10.1074/jbc.M503833200
Reference
  Authors
Buraschi S, Pal N, Tyler-Rubinstein N, Owens RT, Neill T, Iozzo RV
  Title
Decorin antagonizes Met receptor activity and down-regulates {beta}-catenin and Myc levels.
  Journal
J Biol Chem 285:42075-85 (2010)
DOI:10.1074/jbc.M110.172841
Reference
  Authors
Goldoni S, Iozzo RV
  Title
Tumor microenvironment: Modulation by decorin and related molecules harboring leucine-rich tandem motifs.
  Journal
Int J Cancer 123:2473-9 (2008)
DOI:10.1002/ijc.23930
Reference
  Authors
Sofeu Feugaing DD, Gotte M, Viola M
  Title
More than matrix: the multifaceted role of decorin in cancer.
  Journal
Eur J Cell Biol 92:1-11 (2013)
DOI:10.1016/j.ejcb.2012.08.004
Reference
  Authors
Merline R, Moreth K, Beckmann J, Nastase MV, Zeng-Brouwers J, Tralhao JG, Lemarchand P, Pfeilschifter J, Schaefer RM, Iozzo RV, Schaefer L
  Title
Signaling by the matrix proteoglycan decorin controls inflammation and cancer through PDCD4 and MicroRNA-21.
  Journal
Sci Signal 4:ra75 (2011)
DOI:10.1126/scisignal.2001868
Reference
  Authors
Teng YH, Aquino RS, Park PW
  Title
Molecular functions of syndecan-1 in disease.
  Journal
Matrix Biol 31:3-16 (2012)
DOI:10.1016/j.matbio.2011.10.001
Reference
  Authors
Derksen PW, Keehnen RM, Evers LM, van Oers MH, Spaargaren M, Pals ST
  Title
Cell surface proteoglycan syndecan-1 mediates hepatocyte growth factor binding and promotes Met signaling in multiple myeloma.
  Journal
Blood 99:1405-10 (2002)
DOI:10.1182/blood.V99.4.1405
Reference
  Authors
Fux L, Ilan N, Sanderson RD, Vlodavsky I
  Title
Heparanase: busy at the cell surface.
  Journal
Trends Biochem Sci 34:511-9 (2009)
DOI:10.1016/j.tibs.2009.06.005
Reference
  Authors
Purushothaman A, Chen L, Yang Y, Sanderson RD
  Title
Heparanase stimulation of protease expression implicates it as a master regulator of the aggressive tumor phenotype in myeloma.
  Journal
J Biol Chem 283:32628-36 (2008)
DOI:10.1074/jbc.M806266200
Reference
  Authors
Beauvais DM, Ell BJ, McWhorter AR, Rapraeger AC
  Title
Syndecan-1 regulates alphavbeta3 and alphavbeta5 integrin activation during angiogenesis and is blocked by synstatin, a novel peptide inhibitor.
  Journal
J Exp Med 206:691-705 (2009)
DOI:10.1084/jem.20081278
Reference
  Authors
Mahtouk K, Tjin EP, Spaargaren M, Pals ST
  Title
The HGF/MET pathway as target for the treatment of multiple myeloma and B-cell lymphomas.
  Journal
Biochim Biophys Acta 1806:208-19 (2010)
DOI:10.1016/j.bbcan.2010.07.006
Reference
  Authors
Munesue S, Kusano Y, Oguri K, Itano N, Yoshitomi Y, Nakanishi H, Yamashina I, Okayama M
  Title
The role of syndecan-2 in regulation of actin-cytoskeletal organization of Lewis lung carcinoma-derived metastatic clones.
  Journal
Biochem J 363:201-9 (2002)
DOI:10.1042/bj3630201
Reference
  Authors
Nugent MA, Iozzo RV
  Title
Fibroblast growth factor-2.
  Journal
Int J Biochem Cell Biol 32:115-20 (2000)
DOI:10.1016/S1357-2725(99)00123-5
Reference
  Authors
Baciu PC, Saoncella S, Lee SH, Denhez F, Leuthardt D, Goetinck PF
  Title
Syndesmos, a protein that interacts with the cytoplasmic domain of syndecan-4, mediates cell spreading and actin cytoskeletal organization.
  Journal
J Cell Sci 113 Pt 2:315-24 (2000)
Reference
  Authors
Thodeti CK, Albrechtsen R, Grauslund M, Asmar M, Larsson C, Takada Y, Mercurio AM, Couchman JR, Wewer UM
  Title
ADAM12/syndecan-4 signaling promotes beta 1 integrin-dependent cell spreading through protein kinase Calpha and RhoA.
  Journal
J Biol Chem 278:9576-84 (2003)
DOI:10.1074/jbc.M208937200
Reference
  Authors
Beauvais DM, Rapraeger AC
  Title
Syndecans in tumor cell adhesion and signaling.
  Journal
Reprod Biol Endocrinol 2:3 (2004)
DOI:10.1186/1477-7827-2-3
Reference
  Authors
Morgan MR, Humphries MJ, Bass MD
  Title
Synergistic control of cell adhesion by integrins and syndecans.
  Journal
Nat Rev Mol Cell Biol 8:957-69 (2007)
DOI:10.1038/nrm2289
Reference
  Authors
Filmus J, Capurro M, Rast J
  Title
Glypicans.
  Journal
Genome Biol 9:224 (2008)
DOI:10.1186/gb-2008-9-5-224
Reference
  Authors
Filmus J, Capurro M
  Title
Glypican-3: a marker and a therapeutic target in hepatocellular carcinoma.
  Journal
FEBS J 280:2471-6 (2013)
DOI:10.1111/febs.12126
Reference
  Authors
Gao W, Ho M
  Title
The role of glypican-3 in regulating Wnt in hepatocellular carcinomas.
  Journal
Cancer Rep 1:14-19 (2011)
Reference
  Authors
Filmus J, Capurro M
  Title
The role of glypicans in Hedgehog signaling.
  Journal
Matrix Biol 35:248-52 (2014)
DOI:10.1016/j.matbio.2013.12.007
Reference
  Authors
Cheng W, Tseng CJ, Lin TT, Cheng I, Pan HW, Hsu HC, Lee YM
  Title
Glypican-3-mediated oncogenesis involves the Insulin-like growth factor-signaling pathway.
  Journal
Carcinogenesis 29:1319-26 (2008)
DOI:10.1093/carcin/bgn091
Reference
  Authors
Iozzo RV, Sanderson RD
  Title
Proteoglycans in cancer biology, tumour microenvironment and angiogenesis.
  Journal
J Cell Mol Med 15:1013-31 (2011)
DOI:10.1111/j.1582-4934.2010.01236.x
Reference
  Authors
Nikitovic D, Katonis P, Tsatsakis A, Karamanos NK, Tzanakakis GN
  Title
Lumican, a small leucine-rich proteoglycan.
  Journal
IUBMB Life 60:818-23 (2008)
DOI:10.1002/iub.131
Related
pathway
bacu04010  MAPK signaling pathway
bacu04020  Calcium signaling pathway
bacu04066  HIF-1 signaling pathway
bacu04150  mTOR signaling pathway
bacu04151  PI3K-Akt signaling pathway
bacu04210  Apoptosis
bacu04310  Wnt signaling pathway
bacu04340  Hedgehog signaling pathway
bacu04350  TGF-beta signaling pathway
bacu04370  VEGF signaling pathway
bacu04510  Focal adhesion
bacu04520  Adherens junction
bacu04810  Regulation of actin cytoskeleton
KO pathway
ko05205   
LinkDB

DBGET integrated database retrieval system